The concomitant usage of oxycodone HCl with all cytochrome P450 3A4 inhibitors may possibly cause a rise in oxycodone plasma concentrations, which could boost or lengthen adverse reactions and will trigger perhaps lethal respiratory depression. Additionally, discontinuation of the concomitantly applied cytochrome P450 3A4 inducer may end in a rise